Daymark Wealth Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$494K Buy
4,183
+351
+9% +$40.5K 0.01% 485
2026
Q1
$458K Buy
3,832
+920
+32% +$121K 0.01% 446
2025
Q4
$397K Buy
2,912
+33
+1% +$4.75K 0.01% 442
2025
Q3
$425K Buy
2,879
+120
+4% +$16.6K 0.01% 415
2025
Q2
$357K Sell
2,759
-52
-2% -$6.3K 0.01% 419
2025
Q1
$336K Sell
2,811
-31
-1% -$3.84K 0.01% 392
2024
Q4
$330K Buy
2,842
+76
+3% +$9.61K 0.01% 392
2024
Q3
$374K Sell
2,766
-36
-1% -$4.82K 0.02% 387
2024
Q2
$380K Buy
2,802
+681
+32% +$92.6K 0.02% 363
2024
Q1
$274K Sell
2,121
-362
-15% -$43.7K 0.01% 362
2023
Q4
$284K Buy
2,483
+12
+0.5% +$1.2K 0.02% 327
2023
Q3
$225K Sell
2,471
-89
-3% -$9.18K 0.02% 345
2023
Q2
$288K Buy
2,560
+5
+0.2% +$529 0.02% 302
2023
Q1
$268K Buy
2,555
+264
+12% +$27.6K 0.04% 250
2022
Q4
$253K Buy
+2,291
New +$240K 0.04% 200

Other funds holding XYL

Daymark Wealth Partners's XYL Position: Q2 2026 in Review

Daymark Wealth Partners increased its Xylem (XYL) stake by 9.2% in Q2 2026, buying an estimated $40.5K and bringing the position to 4,183 shares worth $494K. The position accounts for 0.01% of the portfolio, ranked #485.

Daymark Wealth Partners first reported a position in XYL in Q4 2022 and has held it in 15 quarters since. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Daymark Wealth Partners held 4,183 shares of Xylem worth $494K as of Q2 2026.
  • Daymark Wealth Partners bought 351 Xylem shares in Q2 2026, an estimated $40.5K.
  • Xylem made up 0.01% of Daymark Wealth Partners's portfolio in Q2 2026, its #485 holding.
  • Daymark Wealth Partners first reported a position in Xylem in Q4 2022 and has held it in 15 quarters since.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.